Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1021535-38-5

Post Buying Request

1021535-38-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1021535-38-5 Usage

General Description

3-(1,7-dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-methylbenzoic acid is a chemical compound with a complex molecular structure. It belongs to the class of benzoic acids and contains a naphthyridine core with a dimethyl and methyl substitution. This chemical compound may have potential pharmaceutical applications due to its unique structure, which could potentially interact with biological systems or target specific disease pathways. Further research and testing are needed to fully understand the properties and potential uses of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1021535-38-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,1,5,3 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1021535-38:
(9*1)+(8*0)+(7*2)+(6*1)+(5*5)+(4*3)+(3*5)+(2*3)+(1*8)=95
95 % 10 = 5
So 1021535-38-5 is a valid CAS Registry Number.

1021535-38-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1,7-dimethyl-2-oxo-1,6-naphthyridin-3-yl)-4-methylbenzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1021535-38-5 SDS

1021535-38-5Relevant articles and documents

COMPOSITIONS AND METHODS FOR MODULATING C-KIT AND PDGFR RECEPTORS

-

Page/Page column 38; 39, (2008/12/05)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit, PDGFR , PDGFR , CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGF , SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2 , BRK, KDR, c-raf or b-raf kinase, or mutant forms thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1021535-38-5